U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07270042) titled 'Evaluation the Efficacy of Zinc on Botulinum Toxin A Injection' on Nov. 18.
Brief Summary: This clinical trial seeks to investigate a promising new approach to enhance the effectiveness and duration of Botulinum Toxin A (BTX-A) for the treatment of hyperactive masseter muscles. By investigating the role of oral zinc supplementation, this study could provide a cost-effective, sustainable solution for patients suffering from both aesthetic concerns and functional limitations associated with MMH and bruxism. The findings of this study will expand the clinical applications of BTX-A, offering longer-lasting relief and reducing the need fo...